/People

Simeon J. George

Investor

Partner at SR One Capital Management

Reedsburg, Wisconsin, United States

Find your path to Simeon

Sign up to see every warm intro you have to Simeon

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Simeon. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Simeon J. George is CEO and co-founder of SR One Capital Management, a trans-Atlantic biotechnology venture capital firm that spun out of GSK in 2020 and maintains offices in the Bay Area and London. The firm invests in biotechnology companies with the aim of developing new medicines for areas of unmet medical need.

Contact· self-published, not guessed

Deals · 1

Bird Rock BioBoard seat

via SR One Capital Management · filed Jan 2017 · $2.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: SEC Form D filings · curated public sources.

Colleagues at SR One Capital Management

Network1

Investors connected to Simeon in public investor directories — a warm-intro map.

Frequently asked questions

Who is Simeon J. George?
Simeon J. George is CEO and co-founder of SR One Capital Management, a trans-Atlantic biotechnology venture capital firm that spun out of GSK in 2020 and maintains offices in the Bay Area and London. The firm invests in biotechnology companies with the aim of developing new medicines for areas of unmet medical need.
Where does Simeon J. George work?
Simeon J. George is Partner at SR One Capital Management.
What boards does Simeon J. George sit on?
Simeon J. George holds tracked board seats at Bird Rock Bio, CRISPR.
What companies has Simeon J. George invested in?
Investments tracked here include ADARx Pharmaceuticals, Anaphore, Bird Rock Bio, CRISPR, Design Therapeutics, Fore Biotherapeutics, Genocea Biosciences, HTG Molecular Diagnostics, Principia Biopharma, Progyny, Rezo Therapeutics, Semprus BioSciences, and 2 more.

About this profile. Compiled from public sources — SR One Capital Management's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights